The agency stated that the companies promoted compounded versions of GLP-1 medications in ways that implied sameness with FDA approved drugs and obscured the source of the products, including through branding practices that suggested the telehealth firms themselves were the compounders
Semaglutide is a long-acting GLP-1 RA medication that is administered once weekly and is authorized for the treatment of T2D under the brand name Ozempic
Retatrutide is not licensed in the UK and is only available through approved clinical trials
Tirzepatide: SURMOUNT-1 (72 Weeks) The SURMOUNT-1 trial enrolled 2,539 adults with obesity (BMI 30) or overweight with comorbidities
It introduces analyses for metabolite annotation, joint clustering, enrichment tests, spatial alignment, multimodal integration, visualization and seamless software interoperability
By targeting these fibres directly, Pure Impact helps maintain functional muscle, supporting metabolism, posture, and the structural integrity of the body during weight loss